Pseudomyxoma Peritonei: Symptoms, Causes and Care

Pseudomyxoma peritonei is a rare and often surprising cancer that most people have never heard of. It usually begins as a small growth, or polyp, in the appendix. Over time, this polyp can rupture, releasing cancer cells into the abdominal cavity. These cells produce a thick, jelly-like fluid called mucin, which accumulates and earns the condition the nickname “jelly belly.”

Unlike many cancers, it rarely spreads through the bloodstream or lymph system, staying mostly within the abdomen. Yet, the growing mucin can press on vital organs like the stomach, liver, and intestines, disrupting digestion and organ function. Symptoms are often subtle and slow to appear, making early detection challenging.

In this blog, we’ll break down how pseudomyxoma peritonei develops, the signs to watch for, how it’s diagnosed, and the intensive treatments used to manage this complex disease.

What is Pseudomyxoma peritonei?

Pseudomyxoma peritonei (PMP) is a rare and serious condition marked by the accumulation of thick, jelly-like fluid (mucin) in the abdominal cavity. It usually begins with a mucin-producing tumour in the appendix, which can eventually rupture, releasing cells into the peritoneal lining. These cells implant on abdominal surfaces, continuing to grow and secrete mucin, gradually filling the abdomen and compressing organs. While the cells may appear only mildly abnormal under a microscope, their relentless production of mucin makes PMP life-threatening if untreated.

What are the symptoms of pseudomyxoma peritonei?

Pseudomyxoma peritonei grows slowly, so early stages often go unnoticed. Many people are only diagnosed by chance during surgery for unrelated issues, like appendicitis or hernia repair. Over time, as the jelly-like mucin builds up in the abdomen, it takes up space meant for healthy organs, leading to noticeable symptoms. Common signs of PMP include:

• Abdominal distension: A gradual or sudden increase in waist size, often mistaken for weight gain.
• Abdominal pain: Pressure from the mucin can cause dull aches or sharp localised pain.
• Constipation: Mucin can compress the intestines causing constipation, slowing bowel movements.
• Difficulty getting pregnant: In women, mucin may affect the ovaries and fallopian tubes, impacting fertility.
• Hernias: Increased abdominal pressure can push contents through weak spots in the abdominal wall.
• Loss of appetite: Stomach compression can cause early fullness after small meals.
• Nausea: Pressure on the digestive tract may lead to persistent nausea or vomiting in advanced stages.

What causes pseudomyxoma peritonei?

Pseudomyxoma peritonei usually starts from a rare polyp in the appendix made of cells that produce too much mucin. When the appendix can’t hold the growing mucin, it can rupture, spreading these cells throughout the abdominal lining. Once settled, the cells keep producing the jelly-like fluid, gradually filling the abdomen. This condition is very rare, affecting only 1–4 people per million each year, and is typically treated at specialised centres with experience in managing peritoneal cancers.

How is pseudomyxoma peritonei diagnosed?

Diagnosing pseudomyxoma peritonei requires a combination of blood tests, imaging, and sometimes surgical evaluation. Because its symptoms can resemble common digestive issues, careful investigation is needed to confirm the disease and assess its extent.

Comprehensive Blood Analysis

Doctors usually start with a complete blood count (CBC) to check for anaemia or infection. They also test for tumour markers like CEA (carcinoembryonic antigen), CA-125, and CA19-9. Elevated levels of these markers don’t confirm PMP on their own but can strongly suggest its presence and help track treatment progress.

Advanced Imaging Evaluations

• Abdominal Ultrasound: Uses sound waves to detect fluid in the abdomen and organ changes.
• CT Scan: Provides detailed cross-sectional images, highlighting “scalloping” on the liver or spleen, a hallmark of mucin pressure.
• MRI: Offers detailed views of soft tissues and helps surgeons plan complex operations.

Histopathological and Surgical Investigation

A definitive diagnosis often requires examining tissue or fluid under a microscope. This can be done via a needle biopsy or through a laparoscopy, a minimally invasive procedure where a small camera allows the surgeon to see the mucin directly and collect precise samples. This ensures accurate staging and guides treatment decisions.

How is pseudomyxoma peritonei treated?

Treating pseudomyxoma peritonei is complex and depends on the patient’s health and how far the disease has spread. The main approach combines surgery to remove visible tumour and mucin with heated chemotherapy to target any remaining cancer cells. Several specific procedures may be performed depending on which organs are affected:

• Cytoreductive Surgery (CRS): Removes as much visible tumour and mucin as possible.
  
   
• Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Heated chemotherapy is applied in the abdomen for 60–90 minutes to kill microscopic cells.
• Bowel Resection: Removes affected parts of the intestines.
• Cholecystectomy: Removes the gallbladder.
• Hysterectomy and Bilateral Salpingo-oophorectomy: Remove the uterus, ovaries, and fallopian tubes in women.
• Liver Capsulectomy: Strips the liver’s surface to remove tumours without harming the organ.
• Omentectomy: Removes the fatty layer covering abdominal organs.
• Peritonectomy: Removes the lining of the abdominal and pelvic cavities.
• Splenectomy: Removes the spleen if involved.

What are the Complications of the Surgery?

Surgery to remove organs affected by pseudomyxoma peritonei is complex and can carry significant risks. Potential complications include haemorrhage (severe bleeding), infections, or anastomotic leaks, which occur when new connections in the bowel do not heal properly. Because these procedures involve multiple organs and delicate tissues, the risk of serious, life-threatening complications is higher than with standard surgeries. Studies show that about 1% to 2% of patients may die as a result of major surgical procedures, highlighting the importance of performing these operations at experienced centres with specialised surgical teams. Despite these risks, for many patients, surgery remains the most effective option for removing the disease and improving long-term outcomes.

Nonsurgical Treatments for Pseudomyxoma Peritonei

Not all patients can safely undergo the intensive surgery required for pseudomyxoma peritonei. Age, other health conditions, or tumour characteristics may make surgery too risky. In these cases, nonsurgical approaches focus on monitoring and symptom management.

• Active Surveillance: For slow-growing, low-grade disease that isn’t causing symptoms, doctors may adopt a “watch and wait” approach with regular CT scans and tumour marker tests to track progression.
• Palliative Care: When surgery isn’t an option, care focuses on comfort and quality of life. This may include draining excess mucin to relieve pressure, nutritional support, pain management, and other measures to keep patients as comfortable and active as possible.

Conclusion

Pseudomyxoma peritonei is a rare and challenging condition that develops slowly but can have serious consequences if left untreated. Understanding its causes, symptoms, and treatment options, including specialised surgery and nonsurgical management, can help patients and families navigate this complex disease with greater confidence. Early diagnosis and treatment at experienced centres are essential for improving outcomes and maintaining quality of life.

Managing a condition like PMP can be financially and emotionally demanding, especially for non-resident Indians. With Niva Bupa NRI Health Insurance, you can access comprehensive coverage for hospitalisation, specialised treatments, and follow-up care, providing peace of mind no matter where you are in the world. Protect your health today and be prepared for unforeseen medical challenges.

Frequently Asked Questions

Is pseudomyxoma peritonei a terminal illness?

Not necessarily. While it is a serious and potentially life-threatening condition if left untreated, many patients can be cured or live for many years following successful cytoreductive surgery and HIPEC. The prognosis depends heavily on the grade of the tumour and how much of it can be surgically removed.

Can PMP return after surgery?

Yes, there is a risk of recurrence. Because the disease involves microscopic cells that can hide within the abdominal cavity, the condition can return years after the initial treatment. This is why long-term follow-up with regular imaging is essential for all patients.

Is pseudomyxoma peritonei hereditary?

Currently, there is no strong evidence to suggest that PMP is a hereditary condition. Most cases appear to occur sporadically due to random genetic mutations within the cells of the appendix.

What is the difference between ascites and PMP?

Standard ascites is the buildup of watery fluid in the abdomen, often caused by liver cirrhosis or other cancers. Pseudomyxoma peritonei involves the buildup of mucin, which is a thick, gelatinous substance produced by specific tumour cells, making it much harder to drain than typical fluid.

How rare is pseudomyxoma peritonei?

PMP is extremely rare, affecting roughly 1–4 people per million each year. Because most doctors see it only occasionally, many patients are referred to specialised peritoneal cancer centres where experienced teams can provide accurate diagnosis and advanced treatment.

Can PMP affect organs outside the abdomen?

PMP usually remains confined to the abdominal cavity. It rarely spreads through the bloodstream or lymphatic system, so organs outside the abdomen are generally not involved. The main concern is that the mucin buildup can press on organs like the intestines, liver, and stomach, affecting their function.

How long does it take for PMP to develop?

PMP grows very slowly, often over months or years. Early stages may produce no noticeable symptoms, so many cases are discovered accidentally during surgery for appendicitis, hernia repair, or other unrelated conditions. Symptoms gradually appear as mucin accumulates.

Are there lifestyle factors that increase PMP risk?

Currently, there is no evidence linking PMP to lifestyle, diet, or environmental factors. It arises primarily from rare genetic mutations in appendix cells. This makes the disease largely unpredictable, though maintaining overall health is still important.

Can imaging alone confirm PMP?

Imaging tests like CT scans and MRI can strongly suggest PMP by showing fluid buildup or organ scalloping. However, a definitive diagnosis requires examining tissue or fluid under a microscope, usually via biopsy or laparoscopy, to confirm the presence of mucin-producing tumour cells and plan treatment.